RGNT
Regentis Biomaterials

10
Mkt Cap
$35.39M
Volume
3,420.00
52W High
$8.00
52W Low
$6.96
PE Ratio
-6.25
RGNT Fundamentals
Price
$7.18
Prev Close
$7.14
Open
$7.17
50D MA
$7.41
Beta
0.00
Avg. Volume
0.00
EPS (Annual)
$0.9642
P/B
-0.80
Rev/Employee
$0.00
Loading...
Loading...
Regentis Biomaterials Ltd. engages in the development of tissue repair solutions. It focuses on orthopedic treatments through its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue such as inflamed cartilage and bone tissue. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
10

Frequently Asked Questions

What is Market Cap of Regentis Biomaterials Ltd.?
What is the 52-week high for Regentis Biomaterials Ltd.?
What is the 52-week low for Regentis Biomaterials Ltd.?
What is Regentis Biomaterials Ltd. stock price today?
What was Regentis Biomaterials Ltd. stock price yesterday?
What is the PE ratio of Regentis Biomaterials Ltd.?
What is the Price-to-Book ratio of Regentis Biomaterials Ltd.?
What is the 50-day moving average of Regentis Biomaterials Ltd.?
How many employess does Regentis Biomaterials Ltd. has?

Latest RGNT News

View
No RGNT news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.